BRENTWOOD, TN August 13, 2024 – Archimedes, a recognized leader in specialty drug management solutions, has been named to the…
BRENTWOOD, TN August 13, 2024 – Archimedes, a recognized leader in specialty drug management solutions, has been named to the…
As part of our BiosimilarsFirst program, Archimedes will be sharing our success in driving biosimilar adoption for Humira, Remicade, and…
Archimedes Announces BiosimilarsFirstTM, an Industry Leading Program to Drive Biosimilar Adoption in 2024 BRENTWOOD, TN, January 10, 2024 – Archimedes,…
BRENTWOOD, TN August 15, 2023 – Archimedes, a recognized leader in specialty drug management solutions, has been named to the…
ARCHIMEDES RECEIVES 2023 BEST IN BUSINESS AWARD Nashville, TN, MONDAY, MAY 24, 2023 – Archimedes, a recognized leader in specialty…
ARCHIMEDES’ CEO DR. BRENDA MOTHERAL SELECTED AS 2023 WOMEN OF INFLUENCE WINNER. Nashville, TN, MONDAY, FEBRUARY 13, 2023 – Dr.…
Register to view our recent 20-minute webinar detailing the next evolution in employer benefits, specialty pharmacy carve-out. We are offering…
Specialty drug costs are growing at an unsustainable pace and increasingly pose a financial threat to the entire health care…
Archimedes is excited to share this snapshot of some key accomplishments from 2021.
Update your browser to view this website correctly. Update my browser now